 VolitionRx NYSE-A:VNRX said it has signed a global agreement with a market leader in pet healthcare to supply its Nu.Q Vet Cancer Test to veterinarians. According to VolitionRx NYSE-A:VNRX, there are approximately 84 million pet dogs in the US. 